Growth Metrics

Sarepta Therapeutics (SRPT) EPS (Basic) (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Sarepta Therapeutics 1.86 Bn 1.17 Bn 291.52 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 180.15%
Dec 31, 2025 -686.00%
Sep 30, 2025 -124.88%
Jun 30, 2025 143.70%
Mar 31, 2025 -378.79%
Dec 31, 2024 371.43%
Sep 30, 2024 400.00%
Jun 30, 2024 -81.58%
Mar 31, 2024 -50.00%
Dec 31, 2023 265.22%
Sep 30, 2023 -70.37%
Jun 30, 2023 95.39%
Mar 31, 2023 -372.57%
Dec 31, 2022 57.82%
Sep 30, 2022 -10.94%
Jun 30, 2022 -120.83%
Mar 31, 2022 16.08%
Dec 31, 2021 -138.33%
Sep 30, 2021 41.18%
Jun 30, 2021 51.43%
Mar 31, 2021 12.50%
Dec 31, 2020 4.00%
Sep 30, 2020 -29.53%
Jun 30, 2020 -739.13%
Mar 31, 2020 92.72%
Dec 31, 2019 -85.88%
Sep 30, 2019 54.55%
Jun 30, 2019 -249.53%
Mar 31, 2019 47.80%
Dec 31, 2018 -78.26%
Sep 30, 2018 31.14%
Jun 30, 2018 -203.64%
Mar 31, 2018 -48.65%
Dec 31, 2017 52.56%
Sep 30, 2017 32.17%
Jun 30, 2017 -175.16%
Mar 31, 2017 194.44%
Dec 31, 2016 -37.29%
Sep 30, 2016 12.59%
Jun 30, 2016 -3.05%
Mar 31, 2016 9.03%
Dec 31, 2015 -15.20%
Sep 30, 2015 -23.76%
Jun 30, 2015 32.21%
Mar 31, 2015 -37.96%
Dec 31, 2014 -52.11%
Sep 30, 2014 16.47%
Jun 30, 2014 -13.33%
Mar 31, 2014 -226.09%
Dec 31, 2013 81.45%
Sep 30, 2013 -106.67%
Jun 30, 2013 54.55%
Mar 31, 2013 44.07%
Dec 31, 2012 -8.76%
Sep 30, 2012 -702.78%
Jun 30, 2012 146.15%
Mar 31, 2012 -1,200.00%
Dec 31, 2011 66.67%
Sep 30, 2011 -400.00%
Jun 30, 2011 -40.00%
Mar 31, 2011 106.58%
Dec 31, 2010 -2,071.43%
Sep 30, 2010 53.33%